Order Summary | License | Report Price | |
---|---|---|---|
Gemcitabine Hydrochloride Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Injection, Solution), By Type (Generic, Branded), By Indication (Breast Cancer, Non-small Cell Lung Cancer, Pancreatic Cancer, Others), Countries and Companies Report TIPRE00029781 | Single User License | $ 3660 |
Single User License | $ 3660 | |
Grand Total | $ 3660 |